EWU Institutional Repository

Prospect of Doripenem in Bangladesh Pharma Market

Show simple item record

dc.contributor.author Hossain, Shahriar
dc.date.accessioned 2019-02-26T09:47:47Z
dc.date.available 2019-02-26T09:47:47Z
dc.date.issued 12/23/2009
dc.identifier.uri http://dspace.ewubd.edu/handle/2525/2983
dc.description This thesis submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy (B.Pharm) in East West University, Dhaka, Bangladesh. en_US
dc.description.abstract Doripenem is a novel carbapenem drug. It is broad spectrum antibiotic. Effort was given to find about the characteristics of the drug and whether it is suitable to launch in the Bangladesh market. Information was gathered from website, journal and books. For market fisibility study IMS, MIMS and QUIMP was observed. It was found that doripenem is non inferior to meropenem, imipenem and ertapenem. It can be used in the complicated urinary tract infections and complicated intra abdominal infections. Doripenem is not in Bangladesh yet. If it is launched doripenem market size would be 10,00,000 taka and its growth would be 10% first year, 25% second year, 15% in third year. From the information from market fisibilty study, swot analysis and product positioning it may be profitable to launch doripenem in Bangladesh. en_US
dc.language.iso en_US en_US
dc.publisher East West University en_US
dc.relation.ispartofseries ;PHA00049
dc.subject Doripenem in Bangladesh Pharma Market en_US
dc.title Prospect of Doripenem in Bangladesh Pharma Market en_US
dc.type Thesis en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account